Study: CBD May Treat Epidermolysis Bullosa

Cannabidiol (CBD) was found to be an effective treatment for epidermolysis bullosa in a study published by the journal Pediatric Dermatology.

“Epidermolysis bullosa is a rare blistering skin disorder that is challenging to manage because skin fragility and repeated wound healing cause itching, pain, limited mobility, and recurrent infections”, states the study’s abstract. “Cannabidiol, an active cannabinoid found in cannabis, is postulated to have antiinflammatory and analgesic effects.”

Researchers “report 3 cases of self-initiated topical cannabidiol use in patients with epidermolysis bullosa in an observational study”. One patient “was weaned completely off oral opioid analgesics, and all three “reported faster wound healing, less blistering, and amelioration of pain with cannabidiol use.”

Read moreStudy: CBD May Treat Epidermolysis Bullosa

Georgia Medical Marijuana Bill Signed Into Law by Governor

Georgia’s governor has signed into law a measure that significantly expands the state’s limited medical marijuana law.

Governor Nathan Deal signed Senate Bill 16 into law today, roughly a month and a week after it was passed by the full legislature; it passed the Senate with a 45 to 6 vote, and was passed by the House of Representatives with a vote of 167 to 4 vote

The new law greatly expands the list of conditions that qualify an individual to legally use low-THC marijuana medicines (such as oils and tinctures) to include Tourette’s Syndrome, autism spectrum disorder, epidermolysis bullosa, Alzheimer’s disease, AIDS (when “such syndrome is diagnosed as severe or end stage”) and peripheral neuropathy.

Read moreGeorgia Medical Marijuana Bill Signed Into Law by Governor

Georgia House Passes Medical Cannabis Expansion Measure with 167 to 4 Vote

Georgia’s full House of Representatives has voted to expand the state’s medical cannabis law.

Senate Bill 16 was passed by the House today with a 167 to 4 vote; the proposal has already been passed by the full Senate.

The proposed law would expand the list of conditions that qualify an individual to legally use cannabis-based medicines to include Tourette’s Syndrome, autism spectrum disorder, epidermolysis bullosa, Alzheimer’s disease, AIDS (when “such syndrome is diagnosed as severe or end stage”) and peripheral neuropathy.

These conditions would join cancer, ALS, multiple sclerosis, Crohn’s disease, mitochondrial disease, Parkinson’s disease and sickle cell disease as qualifying medical cannabis conditions.

Read moreGeorgia House Passes Medical Cannabis Expansion Measure with 167 to 4 Vote

Georgia Medical Marijuana Bill Passed by House Committee

A key House committee has given approval to a Georgia bill that would greatly expand the state’s medical marijuana program.

Senate Bill 16 would expand a 2015 law that allows for the medical use of cannabis oil by adding six new conditions that qualify someone to become a legal medical cannabis patient. Those conditions are AIDS, autism, Alzheimer’s disease, epidermolysis bullosa, Tourette’s syndrome and peripheral neuropathy.

The bill would also make some other changes, including removing a one-year residency requirement for those wanting to become patients, and altering a quarterly reporting requirement by physicians to a bi-yearly report. Another change is that it allows those from out-of-state to be covered by Georgia’s medical marijuana law for up to 45 days if they are a patient in their home state and have a condition that Georgia’s law covers.

Read moreGeorgia Medical Marijuana Bill Passed by House Committee